ONE-WAYOngoing theme · still written in the latest filings
Supply and reputational risk arising from pharmaceutical quality defects and batch rejection
The risk that changes in pharmaceutical quality, foreign-matter contamination, quality defects or batch rejection will lead to a suspension or restriction of stable supply and damage to the company's reputation.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.